BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11909556)

  • 1. Cyclooxygenase-2 inhibition and renal physiology.
    Harris RC
    Am J Cardiol; 2002 Mar; 89(6A):10D-17D. PubMed ID: 11909556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema.
    Frishman WH
    Am J Cardiol; 2002 Mar; 89(6A):18D-25D. PubMed ID: 11909557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effects of cyclooxygyenase-2-selective inhibitors.
    Brater DC
    J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S15-20; discussion S21-3. PubMed ID: 11992745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors.
    Komers R; Anderson S; Epstein M
    Am J Kidney Dis; 2001 Dec; 38(6):1145-57. PubMed ID: 11728945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.
    Swan SK; Rudy DW; Lasseter KC; Ryan CF; Buechel KL; Lambrecht LJ; Pinto MB; Dilzer SC; Obrda O; Sundblad KJ; Gumbs CP; Ebel DL; Quan H; Larson PJ; Schwartz JI; Musliner TA; Gertz BJ; Brater DC; Yao SL
    Ann Intern Med; 2000 Jul; 133(1):1-9. PubMed ID: 10877734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal tolerance of selective inhibitors of cyclooxygenase type 2].
    Deray G
    Presse Med; 2001 Oct; 30(30):1507-12. PubMed ID: 11712212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of COX-2-selective inhibitors.
    Brater DC; Harris C; Redfern JS; Gertz BJ
    Am J Nephrol; 2001; 21(1):1-15. PubMed ID: 11275626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2-specific inhibitors and the kidney: effect on hypertension and oedema.
    Whelton A
    J Hypertens Suppl; 2002 Sep; 20(6):S31-5. PubMed ID: 12683425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 and the renal renin-angiotensin system.
    Harris RC; Zhang MZ; Cheng HF
    Acta Physiol Scand; 2004 Aug; 181(4):543-7. PubMed ID: 15283769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective inhibitors of type 2 cyclooxygenase: less renal effects than the classical non-steroidal anti-inflammatory agents].
    Chiolero A; Würzner G; Burnier M
    Nephrologie; 2000; 21(8):425-30. PubMed ID: 11213386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 selective inhibitors and the kidney.
    Breyer MD; Hao C; Qi Z
    Curr Opin Crit Care; 2001 Dec; 7(6):393-400. PubMed ID: 11805541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclooxygenase-2 attenuates urinary prostanoid excretion without affecting renal renin expression.
    Kammerl MC; Nüsing RM; Seyberth HW; Riegger GA; Kurtz A; Krämer BK
    Pflugers Arch; 2001 Sep; 442(6):842-7. PubMed ID: 11680616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence-based evaluation of the gastrointestinal safety of coxibs.
    Bombardier C
    Am J Cardiol; 2002 Mar; 89(6A):3D-9D. PubMed ID: 11909555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension.
    Wang JL; Cheng HF; Harris RC
    Hypertension; 1999 Jul; 34(1):96-101. PubMed ID: 10406830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney.
    Fujihara CK; Antunes GR; Mattar AL; Andreoli N; Malheiros DM; Noronha IL; Zatz R
    Kidney Int; 2003 Dec; 64(6):2172-81. PubMed ID: 14633140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
    Galli G; Panzetta G
    G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition.
    Brater DC
    Am J Med; 1999 Dec; 107(6A):65S-70S; discussion 70S-71S. PubMed ID: 10628595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of nonselective NSAIDs and coxibs.
    Weir MR
    Cleve Clin J Med; 2002; 69 Suppl 1():SI53-8. PubMed ID: 12086295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 inhibitors and the kidney.
    Appel GB
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S37-40. PubMed ID: 11695250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage.
    Tanaka A; Hase S; Miyazawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Mar; 300(3):754-61. PubMed ID: 11861778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.